Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uday Popat

Showing results (41-50 of 262) with videos related to

Pageof 27
Sort By:
European Journal of Haematology|November 19, 2016
Predictors of inferior clinical outcome in patients with standard-risk multiple myelomaTalha Badar, Samer Srour, Qaiser Bashir, et al.
Stem Cells Translational Medicine|November 8, 2014
Concise review: umbilical cord blood transplantation: past, present, and futureJavier Munoz, Nina Shah, Katayoun Rezvani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondon, et al.
British Journal of Haematology|February 18, 2011
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of ageScott Samuelson, Brenda M Sandmaier, Helen E Heslop, et al.
Human Immunology|May 3, 2012
Vitamin D receptor upregulation in alloreactive human T cellsRichard W Joseph, Ulas D Bayraktar, Tae Kon Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformationStefan O Ciurea, Marcos de Lima, Sergio Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatmentBetul Oran, Michele Donato, Ana Aleman, et al.
British Journal of Haematology|April 27, 2011
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphomaMichelle Fanale, Luis Fayad, Barbara Pro, et al.
JCO Oncology Practice|January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamideRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Haematologica|February 27, 2025
Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndromePortia Smallbone, Terri Lynn Shigle, Oren Paslovsky, et al.
Pageof 27

Showing results (41-50 of 262) with videos related to

Sort By:
Pageof 27
European Journal of Haematology|November 19, 2016
Predictors of inferior clinical outcome in patients with standard-risk multiple myelomaTalha Badar, Samer Srour, Qaiser Bashir, et al.
Stem Cells Translational Medicine|November 8, 2014
Concise review: umbilical cord blood transplantation: past, present, and futureJavier Munoz, Nina Shah, Katayoun Rezvani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondon, et al.
British Journal of Haematology|February 18, 2011
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of ageScott Samuelson, Brenda M Sandmaier, Helen E Heslop, et al.
Human Immunology|May 3, 2012
Vitamin D receptor upregulation in alloreactive human T cellsRichard W Joseph, Ulas D Bayraktar, Tae Kon Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformationStefan O Ciurea, Marcos de Lima, Sergio Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatmentBetul Oran, Michele Donato, Ana Aleman, et al.
British Journal of Haematology|April 27, 2011
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphomaMichelle Fanale, Luis Fayad, Barbara Pro, et al.
JCO Oncology Practice|January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamideRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Haematologica|February 27, 2025
Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndromePortia Smallbone, Terri Lynn Shigle, Oren Paslovsky, et al.
Pageof 27